News Quantified

AYTU – aytu biopharma, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Attention Deficit Hyperactivity Disorder Market to hit USD 24.6 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer [Yahoo! Finance]

Aytu BioPharma Disclosure Notification [Yahoo! Finance]

Aytu BioPharma Disclosure Notification

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]

Form 8-K AYTU BIOPHARMA, INC For: Dec 03

Form SC 13G/A AYTU BIOPHARMA, INC Filed by: Stonepine Capital Management, LLC

Form 10-Q AYTU BIOPHARMA, INC For: Sep 30

Form 4 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J

Form 3 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J

Top News Gainers

3/10 Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test 489.1%

3/13 Form 8-K AYTU BIOSCIENCE, INC For: Mar 12 39.8%

3/20 Form 424B5 AYTU BIOSCIENCE, INC 38.5%

6/4 Aytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in China 16.7%

3/12 Form SC 13G AYTU BIOSCIENCE, INC Filed by: SABBY MANAGEMENT, LLC 16.5%

11/19 Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National Formulary 15.9%

12/11 Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC 14.7%

12/23 Form DEF 14A AYTU BIOSCIENCE, INC For: Jan 24 12.9%

4/30 Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid Test 9.3%

10/16 Aytu BioScience to Announce Results from Natesto(R) Spermatogenesis Study on Thursday, October 17 8.9%

Top News Decliners

3/11 Aytu Announces $9.0 Million Registered Direct Offering Priced At-the-Market -45.6%

3/12 Form 8-K AYTU BIOSCIENCE, INC For: Mar 09 -36.1%

3/19 Form 8-K AYTU BIOSCIENCE, INC For: Mar 13 -27.0%

9/26 Aytu BioScience EPS misses by $1.33, misses on revenue [Seeking Alpha] -19.1%

11/14 Form 8-K AYTU BIOSCIENCE, INC For: Nov 14 -18.6%

4/23 Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited -15.6%

3/30 AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order Related to the COVID-19 Crisis -15.2%

4/21 INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Aytu BioScience, Inc. (AYTU) on Behalf of Investors -15.1%

2/13 Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] -14.5%

4/1 Form 8-K AYTU BIOSCIENCE, INC For: Mar 31 -13.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day